Influence of Personal Respiratory and Visual Protective Equipment on the Development and Progression of Dry Eye Syndrome

Purpose. To study the influence of personal protective equipment (PPE) of the respiratory and visual systems on the development and progression of dry eye syndrome (DES) and its relationship with other risk factors for medical workers.

Patients and methods. The data of 243 people (male — 22.2 %, female — 77.8 %) were analyzed as part of a multi-center analytical scientific one-step study. Total tear production (Schirmer I test) was studied at the beginning and the end of the working day in persons used PPE of respiratory system (disposable medical face mask, gauze masks or different types of respirators), as well as PPE of the eyes (protective half-closed/closed glasses or protective screens). Risk factors for the development and progression of DES were registered (age, smoking, systemic hormones intake, soft contact lenses), as well as the use of artificial tears.

Results. A decrease in the Schirmer I test score at the end of a 7–8 hour work shift was found by an average of 3 mm (from 13 (9; 16) mm to 10 (6; 15) mm, p < 0.001). Statistically significant changes were typical mainly for medical personnel (p < 0.001) with the maximum severity in persons working in outpatient sector. The presence of at least one DES risk factor was found in 30.5 % of patients, two factors — in 3.0 %, and three or more — in 7.0 %. There was no influence of risk factors on the degree of changes in total tear production. Reduced tear production is typical for some PPE of respiratory system (disposable masks and respirators) and the eye (screens and half-closed glasses) (p < 0.001). In people who do not use PPE of the eye, significant changes were detected only in the presence of risk factors.

Conclusion. The negative influence of various PPE of the respiratory system and eye on the total tear production was established. The decrease in the results of the Schirmer I test by the end of the working day was 20–25 % of the basic level, regardless of the presence of traditional risk factors for DES. The severity of changes depended on the type of PPE used. The data obtained are particularly relevant during the new COVID-19 coronavirus pandemic and justify the need to establish specific prophylactic measures. One of the possible methods is the preventive use of artificial tears. 

1. Ministry of health of the Russian Federation. Temporary guidelines. Рrevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 7 (03.06.2020). 2020:165. Available from: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_%D0%9CR_COVID-19_v7.pdf [Accessed 26 June 2020] (In Russ.).

2. Gazizova I.R., Desheva Y.A., Gavrilova T.V., Chereshnev V.A. The prevalence of conjunctivitis in patients with novel coronavirus (covid-19) and preventive measures. Russian Medical Journal. Clinical Ophthalmology = Rossijskiy medicinskiy zhurnal. Klinicheskaya oftal’mologiya. 2020;20(2):92–96 (In Russ.). DOI: 10.32364/2311-7729-2020-20-2-92-96

3. Brzhesky V.V. Dry Eye Syndrome. In book: Opthalmology. National Guideline. 2nd edit. Avetisov S.E., Egorov E.A., Moshetova L.K., Neroev V.V., Tahchidi H.P., eds. Moscow: GEOTAR-Media, 2018:402–417 (In Russ.).

4. Brzhesky V.V. Dry eye syndrome: a disease of the civilization. diagnosis and treatment options. Medical Council = Medicinskiy sovet. 2013;3:114–116 (In Russ.). DOI: 10.21518/2079-701X-2013-3-114-116

5. Brzhesky V.V., Astakhov Y.S., Kuznetzova N.Y. Diseases of the lacrimal apparatus. Guideline for practitioners. Saint Peterburg: Publ. N-L; 2009: 108. (In Russ.).

6. Chu D.K., Akl E.A., Duda S. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis Lancet. 2020;395(10242):1973–1987. DOI: 10.1016/S0140-6736(20)31142-9

7. Dockery D.M., Rowe S.G., Murphy M.A., Krzystolik M.G. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention. J Emerg Med. 2020;S0736-4679(20)30398-X. DOI: 10.1016/j.jemermed.2020.04.060

8. Giannaccare G., Vaccaro S., Mancini A., Scorcia V. Dry eye in the COVID-19 era: how the measures for controlling pandemic might harm ocular surface. Graefes Arch Clin Exp Ophthalmol. 2020 Jun 19 : 1–2. DOI: 10.1007/s00417-020-04808-3

9. Gorenkov R.V., Ryabtseva A.A., Agafonov B.V. Dry eye syndrome in general medical practice. Effective pharmacotherapy = Effektivnaya farmakoterapiya. 2019;15(33):30–36 (In Russ.). DOI: 10.33978/2307-3586-2019-15-33-30-36

10. Brzhesky V.V., Somov E.E. Corneoconjunctival xerosis (diagnostic, clinic, treatment). Saint Peterburg: Saga; 2002: 142. (In Russ.).

11. Egorov E.A. Features of dry eye syndrome treatment. Russian Medical Journal. Clinical Ophthalmology = Rossijskiy medicinskiy zhurnal. Klinicheskaya oftal’mologiya. 2018;18(3):146–149 (In Russ.). DOI: 10.21689/2311-7729-2018-18-3-146-149

12. Egorov E.A., Romanova T.B., Rybakova E.G., Oganezova J.G. Secondary dry eye syndrome: a modern view. Russian Medical Journal. Clinical Ophthalmology = Rossijskiy medicinskiy zhurnal. Klinicheskaya oftal’mologiya. 2017;17(2):106–110 (In Russ.). DOI: 10.21689/2311-7729-2017-17-2-106-110

13. Polunin G.S., Polunina E.G. From dry eye to team film disease. Оphthalmology in Russia = Oftal’mologiya. 2012;9(2):4–7 (In Russ.). DOI: 10.18008/1816-5095-2012-2-4-7

14. Polunin G.S., Safonova T.N., Polunina E.G. New clinical classification of Dry eye syndrome. Refractive surgery and ophthalmology = Refraktsionnaya khirurgiya i oftal’mologiya. 2003;3(3):53–56 (In Russ.).

15. Polunina E.G. Dry Eye syndrome. Оphthalmology in Russia = Oftal’mologiya. 2004;1(2):53–61 (In Russ.).

16. Brzhesky V.V., Egorova G.B., Egorov E.A. «Dry eye» syndrome and ocular surface diseases: clinics, diagnosis, treatment. Moscow: GEOTAR-Media; 2016: 464. (In Russ.).

17. Rational pharmacotherapy in Ophthalmology. Guideline for the practitioners. Ed. E.A. Egorov. Moscow: Littera; 2004: 954. (In Russ.).

18. Somov E.E., Obodov V.A. Tear dysfunction syndrome (anatomic-physiological basis, diagnostics, clinics and treatment). Saint Peterburg: Chelovek; 2011: 160. (In Russ.).

19. Abysheva L.D., Avdeev R.V., Alexandrov A.S. Influence of local hypotensive glaucoma therapy on the development and progression of dry eye syndrome. Russian Medical Journal. Clinical Ophthalmology = Rossiyskiy medicinskiy zhurnal. Klinicheskaya oftal’mologiya. 2017;17(2):74–82 (In Russ.). DOI: 10.21689/2311-7729-2017-17-2-74-82

20. Kuroyedov A.V., Nagornova Z.M., Seleznev A.V. Influence of different local hypotensive therapy regimens on the development and progression of the “dry eye” syndrome. National Journal glaucoma = Natsional’nyi zhurnal glaucoma. 2017;16(3):71–80 (In Russ.).